Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
NHFPC Publishes Reorganization Plan (with Thorough Summary)
The National Health and Family Planning Commission published its reorganization plan which contains its approved main responsibilities, internal departments and personnel... (6/18/2013)
   
BioSpectrum Releases Asia's Fastest 50 Bioscience Companies (6/12/2013)
China's Healthcare Choice: Innovation or Access? (External) (6/11/2013)
Joseph Jimenez: China to Remain Top Priority for Novartis (6/11/2013)
Applying "Innovation Arbitrage" to Develop Novel Medicines in China (5/31/2013)
2012 IMS China Pharmaceutical Market Review (4) - Retail Sales (5/30/2013)
2012 IMS China Pharmaceutical Market Review (3) - Formulated TCMs (5/30/2013)
Pharma Industry Remains Proactive Despite Essential Drug Uncertainties (5/27/2013)
2012 IMS China Pharmaceutical Market Review (2) - Overview (5/21/2013)
2012 IMS China Hospital Pharmaceutical Market Snapshot (1) (5/21/2013)
With a Band of Biotech Collaborators, RuiYi Sets Sail Developing New Biologic Drugs for China (5/16/2013)
New Developments in RDPAC Code of Practice 2012 (5/14/2013)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in Q1/2013 (5/10/2013)
Comparative Review of China's National Essential Drug List: 2012 Ed. vs. 2009 Ed. (5/7/2013)
"Secondary Bargaining" Cannot Solve High Cost of Medical Treatment (5/5/2013)
China Looks to Tighten Excipient Regulations with Limited Resources (External) (5/2/2013)
Hisun Licenses Cell Line from Horizon Di...  (6/18/2013)
NHFPC Publishes Reorganization Plan (wit...  (6/18/2013)
Chinese Diabetes Drug Market to Maintain...  (6/17/2013)
Sichuan BoXin LaiTe Biotech, UBC Enter R...  (6/17/2013)
Chinese Biotech Startup Licenses from UN...  (6/17/2013) (free)
Chinese M&A Climate to Heat Up in 20...  (6/14/2013)
CFDA Talks to J&J over Drug Quality ...  (6/14/2013)
AbbVie Officially Sets Up Shop in China  (6/14/2013)
BMS and Simcere Expands Strategic Partne...  (6/14/2013)
CFDA Deputy Commissioner YIN Li Meets Se...  (6/14/2013) (free)
GSK's Internal Investigation Found No Ev...  (6/14/2013)
Chinese Prostatic Hyperplasia (PH) Drug ...  (6/12/2013)
New Study Reveals China's Alzheimer's Ti...  (6/11/2013)
Study: Chinese in Good Health Longer Tha...  (6/11/2013)
Vectura to Register Recipharm's Asmasal ...  (6/11/2013)
New Report: Global Pharma Industry to Rise 3.7% to US$1....
Global Biosimilars Market to Reach $2.4 Billion in 2013
Novartis Loses Landmark Patent Case for Glivec
AstraZeneca Announces Another Plan to 5,000 Jobs Globall...
Big Pharma Companies Gear Up Acquisition of Injectable F...
Chinese Diabetes Drug Market to Maintain Double-digit Growth by...
Chinese Prostatic Hyperplasia (PH) Drug Market to Sustanin Doub...
New Report: Chinese OTC Drug Market Grew at 18% CAGR in the Pas...
F&S: Chinese Pharma Market to More Than Double by 2016
Chinese Trade of Western Medicines Rose Modestly in 1Q/2013
Hisun Licenses Cell Line from Horizon Discovery for mAb Prod...
Sichuan BoXin LaiTe Biotech, UBC Enter R&D Partnership
Chinese Biotech Startup Licenses from UNMC
Chinese M&A Climate to Heat Up in 2013
AbbVie Officially Sets Up Shop in China
NHFPC Publishes Reorganization Plan (with Thorough Summa...
CFDA Talks to J&J over Drug Quality and Product Reca...
SFDA's 2011 Annual Statistical Report
CFDA Likely to Postpone Decentralization of GMP Certific...
Seven Central Government Agencies to Crackdown on Pharma...
Chinese Pharma Cos Advised to Use Collaborative Deals to Lev...
NCPC to Appeal U.S. Vitamin C Price-fixing Ruling and Fines
Hebei Welcome and NCPC Ordered to Pay US$162M for Vitamin C ...
Chinese Court Rules against Bayer over Clinical Trial-Relate...
NPC: Basic Healthcare Law under Drafting Process
CCCMHPIE Lines Up with Germany's Blue Inspection for Dru...
CFDA Issues Notice for GMP Confirmation of API Exporters...
China Needs More Work with Preparations for New EU API R...
SFDA Orders Survey of Chemical Drug Exports
Alpharma Renews Purchase Contract with Jinhe Biotech
GSK Investigates Alleged Data Fraud Involving Chinese R&...
Sinovac Files NDA for Its Novel EV71 Vaccine
iBio Gains Chinese Patent for Flu Vaccine Technology
Zensun Announces Ph II Results For Heart Failure Drug
TWi Biotech Gains Chinese Patent for Its Lead Drug Candi...
New Study Reveals China's Alzheimer's Time Bomb
Study: Chinese in Good Health Longer Than People in Othe...
New Study: China Sees Tripling Number of Dementia Patien...
WHO Declares Containment of H7N9 Avian Flu Crisis
Elsevier Enters Strategic Alliance with People's Medical...
Updated: GSK Fires China R&D Head over Misrepresentati...
Latest Executive Moves
New Billionaires Created by Chinese Pharma IPO
Recent Executive Moves
Top Leadership Finalized at the CFDA
CFDA Deputy Commissioner YIN Li Meets Senior EU Delegati...
Upcoming Event: Strategic Alliances for Pharma Innovatio...
Upcoming Event: 3rd Annual Drug Delivery and Formulation...
MOHRSS Releases 2012 Statistics on Human Resources and S...
Upcoming Event: The 3rd Annual Biobank China 2013
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
  Pharma China adds another dist...
  Testimonials from subscribers ...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links